Medicine Products
Osteomesh Bioresorbable Implant for Craniofacial Surgery
Description:Osteomesh is a bioresorbable implant used in craniofacial surgery to repair various types of fractures, like the orbital floor fracture and to fill surgical defects. It has interconnected pores which allow rapid saturation with marrow, blood and nutrients, thus providing the patients own cells with chemical signals that are required for bone growth and remodeling. The mesh is malleable and can be...Company:Osteopore InternationalDescription:AMD Now is a forum presenting interactive education on Age- related Macular Degeneration (AMD), AMD diagnosis and treatments, VEGF, aseptic technique and supportive care for patients and caregivers....
Company:ASORN
SWISSBLADE Diamond Surgical Knives
Description:SWISSBLADE disposable surgical knives single-use blades deliver a consistent, sharp, clean cut due to the low friction coefficient achieved with Ziemers proprietary coating technology. SWISSBLADE diamond surgical knives feature top-of-the-line, reusable blades with the proven superior cutting capabilities based on the diamond expertise of Ziemer Group partner Meyco (Biel, Switzerland) an...Company:ZIEMER USA, Inc.
MAXWELL Optical Wavefront Aberrometer
Description:The MAXWELL Optical Wavefront Aberrometer is an innovative diagnostic instrument with a wide range of functions that permit eye care practitioners and researchers to effectively assess all of the wavefront aberrations present in a subjects eye. This remarkable device offers the widest wavefront diagnostic range and functions on more than 99% of subjects. Beyond its superior performance in wavefro...Company:ZIEMER USA, Inc.
ConstaVac CBCII Blood Conservation System
Description:The Stryker CBCII Blood Conservation System provides a safe, simple and economic disposable system for blood reinfusion....Company:Stryker InstrumentsDescription:The combination of these recommendations with the exceptional design and engineering expertise of the Sorin Group has resulted in numerous improvements, such as: Slim design, integrated IV poles and reservoir holder for hassle-free storage The system easily detaches from the cart with just a flick of the lever, making transportation of the unit convenient and manageable <li...
Company:Sorin Group USA, Inc.Description:Haemonetics invented surgical blood salvage nearly thirty years ago and has been an innovator in the field ever since. The Cell Saver autologous blood recovery systems are used in operating room procedures in which there is rapid bleeding or high-volume blood loss....
Company:Haemonetics
Osteoplug Bioresorbable Implant for Trephination Burr Holes
Description:Posteoplug is a bioresorbable implant that is used for covering trephination burr holes in neurosurgery. This proprietary, user-friendly design, shaped like a flattened button mushroom, allows a snap fit into burr holes and requires no fixation by screws, unlike titanium plates. It has superior mechanical strength and the scaffold architecture minimizes potential injuries to the exposed brain th...Company:Osteopore International
RestorePRIME Neurostimulation System
Description:RESTOREPRIME is the First and Only 16-Electrode Non-Rechargeable Neurostimulator. Medtronic combined the powerful technology of RESTORE with the convenience of a non-rechargeable neurostimulator to create the unrivaled RESTOREPRIME. The ultimate non-rechargeable device, RESTOREPRIME offers flexibility and coverage for managing patients with bilateral and complex pain with low to modera...Company:Medtronic Neurological and Spinal
Rapid Programmer 3.0 Neurostimulation Programming Platform
Description:The Rapid Programmer 3.0 is the smallest and lightest-weight clinician programming platform in the industry. It enables clinicians to quickly and efficiently test patients intraoperatively and to create programs for them postoperatively....Company:Advanced Neuromodulation Systems, Inc.
(Date:12/1/2008)...LE, Md., Dec. 1 Vapothe...products, announced today that President and CEO, ...ual health care conference on Wednesday, December .... , , The conference brings together publi...care sectors to present and discuss trends, advanc...
(Date:12/1/2008)...SON, Wis., Dec. 1 EMS Magazine, th...edical services market, recently,announced the wi...which,recognize some of the industry,s most innov...en by industry experts and EMS Magazine Editorial ...wards were presented at the Texas EMS,State Confe...
(Date:12/1/2008)...ON, Mass., Dec. 1 Pressu...he "Company") today announced a comprehensive rest... costs, centralize core operations, and refocus th...ere the Company,s products have found significant ...udes: , , -- a reduction in personnel of ei...
(Date:12/1/2008)...DELPHIA) An enzyme that is overexpressed in pancr...y treating the disease with targeted immunotherapy...orted at the 2008 Annual Meeting of the Southern S... protein, indoleamine 2,3-dioxygenase (IDO), is ov...according to Jonathan R. Brody, Ph.D., an assistan...
Breaking Medicine News(10 mins):Health News:EMS Magazine Announces Top Innovation Awards for 2008 2Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 2Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 3Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 4Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 5Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 6Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 7Health News:IDO2 an active enzyme to target in pancreatic cancer 2[0] Vapotherm to Present at the Piper Jaffray 20th Annual Health Care Conference[0] EMS Magazine Announces Top Innovation Awards for 2008[0] Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus[0] IDO2 an active enzyme to target in pancreatic cancer
...Scientists belonging to the Brown University have ...onnected to the aging of the cells. // This conclu...ed between 5 and 30 years, wherein it was found th...s also a significant increase in the ageing cells ...
...How much do we know about the connection between a...biologists have found new proof that might establi...s. // During a study of baboons, it was discovere...showed an increased presence of old cells. It is w...
...Professor Joseph C. Liao from David Geffen School ...iagnostics which helps in early detection of Urina...sed by gram // negative bacteria which colonizes t...Bacterial culture which is used for identification...
...Australia: Mental illness is no better or worse t... to improve the caliber of Mental Health care. The... to Prime Minister John Howard. Preferable, if the...all only the wearer knows exactly where the shoe p...
Other Medicine News:Health News:Link between Old Cells and Ageing probed 2Health News:Australia's Mentally ill, ill at ease with Quality of Care 2Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new
A dual chamber sensing/pacing, rate responsive, 31 J ICD, with ELA's patented PARAD/PARAD+ ventricular tachycardia algorithm.
A single chamber sensing/pacing, rate responsive, 31 J ICD, with a full range of ventricular tachycardia algorithms.
Medicine Products:(Date:11/25/2008)... Audio and Web Video Resources to accompany this... Please see the bottom of this release for details...swire-USNewswire/ -- A Mayo Clinic study shows a m...ing a stroke -- and as a result -- delay seeking t...gs appear in the current issue of Emergency Medici...
(Date:11/25/2008)...e/ -- Proteolix, Inc., a,leader in the discovery ...,protein degradation pathways in cancer and autoim... ongoing Phase 2 clinical trials of carfilzomib in...ng 50th Annual Meeting of the,American Society of...new class,of specific proteasome inhibitors and i...
(Date:11/25/2008)...ss Survival of Patients Receiving Litx versus Stan...ular Carcinoma , , BELLEVUE, Wash., Nov. 25...O) today announced the completion of enrollment in... Therapy(TM) (Litx(TM)) as a treatment for unresec...s hepatoma or primary liver cancer. , , The...
(Date:11/24/2008)...o,s Pizza (NYSE: DPZ ), the,recognized world le...gh for,the kids of St. Jude Children,s Research H... campaign. Domino,s customers will have the opport...benefit the children of St. Jude.,Donations can b...ng online at, www.dominos.com . The campaign begi...
Breaking Medicine Technology:Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3AGA Medical Corporation Receives CE Mark Approval for the AMPLATZER 28R 29 Vascular Plug III 19507 1AGA Medical Corporation Receives CE Mark Approval for the AMPLATZER 28R 29 Vascular Plug III 19507 2Lions Mobilize 241 5 Million for China Earthquake Relief 19505 1Lions Mobilize 241 5 Million for China Earthquake Relief 19505 2Lions Mobilize 241 5 Million for China Earthquake Relief 19505 3Lions Mobilize 241 5 Million for China Earthquake Relief 19505 4Perot Systems Announces the Launch of Xcelys 28TM 29 5 0 Software 19503 1Perot Systems Announces the Launch of Xcelys 28TM 29 5 0 Software 19503 2Ortho Biotech L P and Centocor Inc Alert Authorized Distributors and Prescribing Physicians About Stolen Product 5449 1Ortho Biotech L P and Centocor Inc Alert Authorized Distributors and Prescribing Physicians About Stolen Product 5449 2Ortho Biotech L P and Centocor Inc Alert Authorized Distributors and Prescribing Physicians About Stolen Product 5449 3Ortho Biotech L P and Centocor Inc Alert Authorized Distributors and Prescribing Physicians About Stolen Product 5449 4[1] Do You Know You're Having a Stroke?[1] Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology[0] Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma[1] Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign
...ll/ -- Vical,Incorporated today announced that the...ive results following interim analysis of data,fro...l of an,angiogenesis product candidate using Vical...that the primary efficacy,endpoint in the trial ha...that there were no major safety concerns related,t...
...nd Other Nutrients in,Patients with Mild, Moderate...ms of Exocrine Pancreatic Insufficiency, MILAN, It...rstCall/ -- Eurand N.V. today announced results th...brosis Society,meeting in Antalya, Turkey, held Ju...ntase(TM) (EUR-1008) showing a statistically and,c...
Other Medicine Technology:Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 2Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 3Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 4Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 5Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 6Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 7Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 8| Copyright © 2003-2007 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |